Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor

被引:31
|
作者
Kume, K
Shimizu, T
机构
[1] Dept. of Biochem. and Molec. Biology, Faculty of Medicine, University of Tokyo, Hongo, Bunkyo
[2] Dept. of Biochem. and Molec. Biology, Faculty of Medicine, University of Tokyo, Bunkyo, Tokyo 113
关键词
D O I
10.1074/jbc.272.36.22898
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor (PAF) is a phospholipid mediator with various physiological functions, including cellular growth and transformation. PAF exerts biological activities through G-protein-coupled receptors. In normal rat fibroblasts overexpressing a cloned PAF receptor, PAF induced immediate early oncogene expression and mitogenic responses, On the other hand, PAF strongly inhibited the epidermal growth factor-induced mitogenic growth response, growth acceleration, and anchorage-independent cell growth in a soft agar. Furthermore, PAF suppressed v-src-or v-ras-induced oncogenic morphological changes and anchorage-independent growth. Our observations suggest that PAF is a unique growth regulator with apparently diverse functions. Dual actions of PAF may relate to the point of action in the cell cycle; PAF stimulates the mitogenic response in G(0)-arrested cells in a pertussis toxin-sensitive manner, while it inhibits the G(1) to S transition through a pertussis toxin-resistant manner.
引用
收藏
页码:22898 / 22904
页数:7
相关论文
共 50 条
  • [41] DESENSITIZATION OF HUMAN-PLATELETS BY PLATELET-ACTIVATING FACTOR (PAF)
    CHESNEY, CM
    PIFER, DD
    HUCH, KM
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 977 - 977
  • [42] PLATELET-ACTIVATING FACTOR (PAF-ACETHER) - PRESENT STATUS
    BENVENISTE, J
    AGENTS AND ACTIONS, 1981, 11 (6-7): : 542 - 544
  • [43] STIMULATION OF THE DE-NOVO PATHWAY FOR THE BIOSYNTHESIS OF PLATELET-ACTIVATING FACTOR (PAF) VIA CYTIDYLYLTRANSFERASE ACTIVATION IN CELLS WITH MINIMAL ENDOGENOUS PAF PRODUCTION
    BLANK, ML
    LEE, YJ
    CRESS, EA
    SNYDER, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (12) : 5656 - 5661
  • [44] PLATELET-ACTIVATING FACTOR (PAF) BIOACTIVITY FORMATION AND LYSO-PAF ACCUMULATION IN HUMAN ARTERIES
    Tsoukatos, D. C.
    Moussis, V.
    Panopoulou, C. P.
    Christofidou, E. D.
    Koussissis, S.
    Brocheriou, I.
    Ninio, E.
    Sismanidis, S.
    Siminelakis, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 144 - 144
  • [45] Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
    Bagnis, C
    Deray, G
    Dubois, M
    Pirotzky, E
    Jacquiaud, C
    Baghos, W
    Aupetit, B
    Braquet, P
    Jacobs, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (03) : 507 - 513
  • [46] RELEASE OF PLATELET-ACTIVATING FACTOR (PAF) BY MACROPHAGES DURING PHAGOCYTOSIS
    BENVENISTE, J
    MENCIAHUERTA, JM
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1554 - 1554
  • [47] STRUCTURAL ANALOGS OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER)
    TENCE, M
    COEFFIER, E
    HEYMANS, F
    POLONSKY, J
    GODFROID, JJ
    BENVENISTE, J
    BIOCHIMIE, 1981, 63 (8-9) : 723 - 727
  • [48] Inflammatory actions of platelet-activating factor: Control by PAF acetylhydrolase
    Prescott, SM
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1997, 7 (05): : 416 - 416
  • [49] Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung:: effects of hyperoxia
    Jehle, R
    Schlame, M
    Büttner, C
    Frey, B
    Sinha, P
    Rüstow, B
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2001, 1532 (1-2): : 60 - 66
  • [50] THE EFFECT OF PAF-RECEPTOR ANTAGONIST KADSURENONE ON THE CARDIOVASCULAR EFFECTS IN THE RABBIT INFUSED WITH SYNTHETIC PLATELET-ACTIVATING FACTOR (PAF)
    MONTRUCCHIO, G
    ALLOATTI, G
    MARIANO, F
    SHEN, TY
    TETTA, C
    RAGNI, R
    MEDA, E
    EMANUELLI, G
    CAMUSSI, G
    PROSTAGLANDINS, 1985, 30 (04): : 711 - 711